期刊文献+

临床不安全用药行为研究及成因分析 被引量:11

The Investigation of Actions and Factors Analysis of Irrational Drug Use in Clinic
在线阅读 下载PDF
导出
摘要 目的调查并分析住院患者的用药安全风险状况,为实施合理用药干预提供参考资料和依据。方法采用病例观察方法,监测3所综合医院于2008年5~12月,所有入住呼吸科、心内科、普外科、骨科的患者药物使用全程中的不合理现象,并进行统计学分析。结果 3家医院4 910例患者共出现不合理用药现象1 188例次、24.19%,各项观察指标中给药浓度、间隔时间、无适应证用药出现问题的频率居前3位,分别为308、214、147例次;关联因素分析结果显示人员相关者占半数;473例重点监测病例中不合理用药现象302例次,占60.85%,其中23.68%(112例次)是补充指标的贡献。结论规范临床用药的重点在于提供准确知识、加强管理监督、增强医护人员责任心。 Objective To investigate and analyze the risk of safe drug use in hospital patients and in order to provide reference for administrating intervention of rational drug use.Methods To mornitor and statistical analyze the case of irrationality during whole range of drug use of all the hospital patients in Respiratory,Cardiology,General Surgery and Orthopedics in the three comprehensive hospital from May to December in 2008 with case survey of epidemiology.Results There were 1 188 cases(24.19%) of irrational drug use in 4 910 patients in the three hospitals.The frequency of problems causing by dosing concentration(308 cases),time separation(214 cases) and Non-indication medication(147 cases) were the top three in all the index.The consequence of correlation factor showed that the half had been personal relation.There were 302 cases(60.85%) of irrational drug use in 473 enforce monitoring cases,and 23.68%(112 cases) were provided by additional index.Conclusion The key of standardize drug use in clinic,was to provide accurate knowledge,reinforce supervision and enhance responsibilities of staff in hospitals.
出处 《中国药物警戒》 2010年第12期726-729,共4页 Chinese Journal of Pharmacovigilance
基金 国家科技支撑课题"安全用药关键技术研究与应用"(课题编号2006BAI4B04)子课题
关键词 临床用药 行为 成因分析 drug use in clinic action factor analysis
  • 相关文献

参考文献11

二级参考文献76

共引文献463

同被引文献71

  • 1蔡溱,胡晋红.美国医疗机构药师学会对医院预防药物治疗差错的指导原则[J].药学服务与研究,2005,5(2):206-208. 被引量:13
  • 2王北京.与患者沟通中不可忽略的几个要点[J].中国护理管理,2006,6(7):17-18. 被引量:33
  • 3付晨,张钢.台湾地区医疗卫生管理体制的启示和借鉴[J].中国卫生资源,2007,10(1):24-26. 被引量:59
  • 4Medicines: rational useofmedicines[EB/OL].[2011-03-29].http:// www.who, int/mediacentre/factsheets/fs338/en/index.html.
  • 5Members of EMERGE, the Erice Medication Errors Research Group,Abha Agrawal,etc. Medication errors : problems and recommendations form a consensus meeting[J].British Journal of Clinical Pharmacology.2009,67(6) :.592-508.
  • 6药品不良反应报告和监测管理办法[S].中华人民共和国卫生部令第81号,2011.
  • 7Bates DW, Cullen D J, Laird N. Incidence of adverse drug events. Implications for prevention[J]. JAMA, 1995, 274(1): 29-34.
  • 8Vandoormaal JE, Mol PG, VandenBemt PM, et al. Reliability of the assessment of preventable adverse drug events in daily clinical practice[J]. Pharmacoepidemiol Drug Saf, 2008, 17(7): 645-654.
  • 9Benjamin DM. Reducing medication errors and increasing patient safety: case studies in clinical pharmacology[J]. J Clin Pharmacol, 2003, 43(7): 768-783.
  • 10Man Zhu, Dai-Hong Guo, Gui-Yang Liu, et al. Exploration of clinical pharmacist management system and working model in China[J]. Pharm World Sci, 2010, 32: 411-415.

引证文献11

二级引证文献57

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部